GlassScriptPhysician profile
Katrina Lee Weaver
NPI 1689804759
$30,547.57
in general payments reported to CMS, 2019-2025
10 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $112 · 2021: $6,843 · 2022: $301 · 2023: $10K · 2024: $107 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Honoraria: $6,000 · Travel and Lodging: $3,907 · Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,568.18 |
| Honoraria | $6,000.00 |
| Travel and Lodging | $3,906.80 |
| Food and Beverage | $817.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $20,965.33 | 2020-2025 | Recell, Cohealyx, Permeaderm |
| Intuitive Surgical, INC. | $6,552.67 | 2021 | |
| Kerecis Limited | $2,393.91 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zimvie INC. | $260.45 | 2022 | |
| Ethicon US, LLC | $192.93 | 2020-2021 | |
| Convatec INC. | $83.00 | 2022-2023 | |
| Smith+Nephew, INC. | $44.58 | 2021-2023 | Pico 14 |
| Eton Pharmaceuticals, INC. | $20.39 | 2025 | Increlex, Alkindi, Khindivi |
| Standard Bariatrics, INC. | $17.48 | 2022 | |
| Depuy Synthes Sales INC. | $16.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.